IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
单位:[1]Univ Ulsan, Dept Gastroenterol, Ctr Liver, Asan Med Ctr,Coll Med, Ulsan, South Korea[2]Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Peoples R China[3]Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China[4]Chinese Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China[5]Huazhong Univ Sci & Technol, Dept Infect Dis, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China感染科华中科技大学同济医学院附属同济医院[6]Kings Coll Hosp London, Inst Liver Studies, London, England[7]Univ Hlth Network, Toronto Ctr Liver Dis, Toronto Gen Hosp, Toronto, ON, Canada[8]NYU, Sch Med, Dept Med, Div Gastroenterol & Hepatol,NYU Langone Hlth, New York, NY USA[9]Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan[10]Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Musashino, Tokyo, Japan[11]All India Inst Med Sci, Dept Gastroenterol, New Delhi, India[12]Univ Hosp Pisa, Hepatol Unit, Pisa, Italy[13]Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA[14]Hop Beaujon, AP HP, Dept Hepatol, F-92110 Clichy, France[15]Auckland Clin Studies, Auckland, New Zealand[16]Southern Med Univ, Dept Infect Dis, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China[17]Hosp Gen Univ Valle Hebron, Barcelona, Spain[18]Ciberehd, Barcelona, Spain
第一作者单位:[1]Univ Ulsan, Dept Gastroenterol, Ctr Liver, Asan Med Ctr,Coll Med, Ulsan, South Korea
推荐引用方式(GB/T 7714):
Lim Young-Suk,Chan Henry Lik Yuen,Seto Wai-Kay,et al.IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)[J].HEPATOLOGY.2019,70:126A-127A.
APA:
Lim, Young-Suk,Chan, Henry Lik Yuen,Seto, Wai-Kay,Ning, Qing,Agarwal, Kosh...&Buti, Maria.(2019).IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB).HEPATOLOGY,70,
MLA:
Lim, Young-Suk,et al."IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)".HEPATOLOGY 70.(2019):126A-127A